President Donald Trump just put Washington’s healthcare establishment on notice from Dublin, Ireland.
His message was direct: stop routing federal money through giant insurance companies and put it in the hands of the American people instead.
Speaking at the U.S. Embassy on Saturday, Trump renewed his push for what he calls the Great Healthcare Plan — a proposal designed to let eligible Americans buy coverage themselves and keep any money left over.
"We will pass the Great Healthcare plan to stop all government payments to big insurance companies, and give the money directly to the people, for you to buy your own healthcare and have money left over…" – President Donald J. Trump pic.twitter.com/Pjt7W9N6vX
— The White House (@WhiteHouse) September 12, 2026
That is a fundamental change in who controls the money.
Under the current system, Washington sends enormous sums through insurers and government programs while families are left trying to understand rising premiums, narrow networks and medical bills that rarely resemble the price they expected.
Trump’s argument is that patients should become the customer again.
The White House’s Great Healthcare Plan asks Congress to redirect certain federal insurance payments to eligible Americans rather than sending the money to large insurance companies. The administration says those funds would allow people to purchase the health coverage of their choice, placing individuals and families — not insurers — at the center of the transaction.
The proposal also calls for funding cost-sharing reductions, which the White House projects would save taxpayers at least $36 billion and reduce the most common Obamacare plan premiums by more than 10 percent. It would require insurers to publish how much premium revenue goes to claims, overhead and profits, along with denial rates and average wait times for routine care.
Hospitals and insurers that accept Medicare or Medicaid would have to post prices prominently rather than burying them behind confusing tools. The plan also seeks a Plain English insurance standard so consumers can compare coverage and costs before they sign up, instead of discovering exclusions after a medical need arises.
On prescription drugs, the plan would codify the administration’s Most Favored Nation agreements, expand access to safe over-the-counter medicines and end pharmacy-benefit-manager kickbacks to brokers. Those provisions are aimed at lowering prices while exposing the middlemen who profit from a system few patients can clearly see.
In plain terms, Trump is proposing a market in which insurers have to compete for an informed customer’s business.
That matters because the healthcare debate is usually presented as a choice between two versions of centralized control: government bureaucrats or corporate bureaucrats.
Direct support flips that arrangement. If the money follows the patient, the patient gains leverage.
Plans that deliver value can win customers, and plans that hide prices or deny care can lose them.
The administration argues that its drug-price strategy is already producing results. On Saturday, the Department of Health and Human Services said Trump’s TrumpRx and Most Favored Nation approach has helped secure more than $638 billion in pharmaceutical research, development and manufacturing investment.
.@POTUS has secured more than $638 billion in pharmaceutical research, development, and manufacturing investment thanks to TrumpRx and the Most Favored Nation strategy! 🇺🇸 https://t.co/0B3p4jgrkn
— HHS (@HHSGov) September 12, 2026
There is also a smaller-scale example of what returning healthcare money to citizens can look like.
In a September 10 fact sheet, the White House announced that nearly one million Americans in 30 states will begin receiving $500 Working Families Obamacare Refunds in October. The administration says the refunds come from surplus user fees collected through the federal health-insurance exchange.
The $500 refunds are separate from the broader Great Healthcare Plan; Congress has not yet approved that proposal. They do demonstrate the governing principle Trump is emphasizing: when a federal healthcare program collects more money than it needs, the surplus should go back to the people rather than remain inside the system.
The same fact sheet says the administration had secured 26 pharmaceutical agreements covering nearly 90 percent of the branded-drug market by August 31. It also points to expanded Health Savings Account access for as many as 10 million people and a $50 billion rural-health program intended to support care outside major metropolitan areas.
For families, the test will be tangible: lower premiums, lower prescription costs, transparent prices and more control over where healthcare dollars go. The October refunds offer an immediate benefit for eligible exchange customers, while the larger direct-payment proposal still depends on Congress turning Trump’s framework into law.
That distinction is important. Trump announced an agenda and renewed his call for Congress to pass it; he did not claim that every element is already law.
Now the political choice is becoming clearer.
Lawmakers can defend a system in which taxpayers fund insurers first and patients navigate whatever remains, or they can debate how to move control closer to the people actually paying premiums and receiving care.
There will be real questions to settle — eligibility, payment levels, protections for people with expensive conditions and safeguards against junk plans among them. Congress should answer those questions in public, with actual numbers, instead of using complexity as an excuse to preserve the status quo.
What it should not do is pretend that Americans are satisfied with a healthcare machine that consumes more money while becoming harder to understand.
Trump placed the healthcare push inside a much broader message about the country’s direction during his Dublin remarks:
"Today, I'm proud to report that the United States of America is doing better, literally, better than it's ever done before."
President Trump on American success at the U.S. Embassy in Dublin. 🇺🇸🇮🇪 pic.twitter.com/Qz6bXupdY3
— The White House (@WhiteHouse) September 12, 2026
The healthcare fight will show whether Washington is willing to apply that optimism to one of the biggest expenses in an American family’s budget.
Sending money directly to eligible Americans is one part of a much larger healthcare fight. It starts from a powerful premise that Washington too often forgets: the system is supposed to serve the patient.
Trump has now put that choice in front of Congress.
Featured image: President Donald Trump sits for an interview in the Roosevelt Room of the White House on August 6, 2026. Official White House photo by Molly Riley.
This is a Guest Post from our friends over at WLTReport. View the original article here.
What are your thoughts?
